CD81 通过阻断 CD274/PD-L1 的选择性自噬降解驱动放射抵抗性胶质母细胞瘤的免疫逃逸
CD81 drives immune evasion in radioresistant glioblastoma by blocking selective autophagic degradation of CD274/PD-L1.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Tertiary lymphoid structures in gliomas: impact on tumour immunity and progression.
Tertiary lymphoid structures in gliomas: impact on tumour immunity and progression.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
三级淋巴结构(TLSs)是在慢性炎症组织中形成的异位淋巴结构,包括各种实体瘤。在胶质瘤的背景下,TLSs的存在最近引起了相当大的关注,因为它们在肿瘤免疫学和治疗中具有潜在意义。肿瘤免疫微环境(TIME)在癌症进展中起着至关重要的作用,而肿瘤浸润免疫细胞(TILs)是该环境中的关键参与者。这些免疫细胞聚集体,即TLSs,在不同实体瘤中表现出不同的特征。然而,中枢神经系统(CNS)肿瘤高度异质,这些肿瘤内的免疫环境通常比外周组织肿瘤更为缺陷。这导致CNS肿瘤中TLSs的形成和功能存在差异。这些差异在胶质瘤免疫治疗的背景下尤为重要,并可能对治疗策略产生重要影响。本综述聚焦于TLSs的组成和功能,探讨胶质母细胞瘤(GBM)免疫微环境的复杂性,并强调TLSs在GBM中的独特特征,为胶质瘤免疫治疗中靶向TLSs提供新的理论见解和实践基础。
Tertiary lymphoid structures (TLSs) are ectopic lymphoid formations that develop in chronically inflamed tissues, including various solid tumours. In the context of gliomas, the presence of TLSs has recently attracted considerable attention because of their potential implications in tumour immunology and therapy.
The tumour immune microenvironment (TIME) plays a crucial role in cancer progression, and tumour-infiltrating immune cells (TILs) are key players in this environment. These immune cell aggregates, known as TLSs, display distinct characteristics across different solid tumours.
However, central nervous system (CNS) tumours are highly heterogeneous, and the immune environment within these tumours is often more deficient than that of peripheral tissue tumours. This leads to differences in the formation and function of TLSs in CNS tumours. These variations are particularly relevant in the context of glioma immunotherapy and could have important implications for treatment strategies.
This review focuses on the composition and function of TLSs, examines the complexity of the glioblastoma (GBM) immune microenvironment, and highlights the unique characteristics of TLSs in GBM, providing new theoretical insights and practical foundations for targeting TLSs in glioma immunotherapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。